Epigenetic events, remodelling enzymes and their relationship to chromatin organization in prostatic intraepithelial neoplasia and prostatic adenocarcinoma

To explore the nuclear chromatin phenotype, overall epigenetic mechanisms, chromatin remodelling enzymes and their role as diagnostic biomarkers in prostate lesions, using high‐resolution computerized quantitative digital image analysis (DIA).

[1]  James T Kadonaga,et al.  Chromatin remodeling by ATP-dependent molecular machines. , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[2]  A. Bird,et al.  Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals , 2003, Nature Genetics.

[3]  J. Brooks,et al.  CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[4]  V. Speights,et al.  Global hypomethylation is common in prostate cancer cells: a quantitative predictor for clinical outcome? , 2005, Cancer genetics and cytogenetics.

[5]  Rajvir Dahiya,et al.  Epigenetic changes in prostate cancer: implication for diagnosis and treatment. , 2005, Journal of the National Cancer Institute.

[6]  Robert M. Haralick,et al.  Textural Features for Image Classification , 1973, IEEE Trans. Syst. Man Cybern..

[7]  P H Bartels,et al.  Nuclear chromatin texture in prostatic lesions. I. PIN and adenocarcinoma. , 1998, Analytical and quantitative cytology and histology.

[8]  A. Sasco,et al.  Breast cancer prognostic significance of some modified urinary nucleosides. , 1996, Cancer letters.

[9]  B. Turner,et al.  Histone acetylation as an epigenetic determinant of long-term transcriptional competence , 1998, Cellular and Molecular Life Sciences CMLS.

[10]  P. Bartels,et al.  Diagnostic distance of high grade prostatic intraepithelial neoplasia from normal prostate and adenocarcinoma. , 1997, Journal of Clinical Pathology.

[11]  P. V. van Helden,et al.  Hypomethylation of DNA in pathological conditions of the human prostate. , 1987, Cancer research.

[12]  P. Marks,et al.  Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. , 2000, Journal of the National Cancer Institute.

[13]  P. Bartels,et al.  Statistical histometry of the basal cell/secretory cell bilayer in prostatic intraepithelial neoplasia. , 1998, Analytical and quantitative cytology and histology.

[14]  A. Feinberg,et al.  Hypomethylation distinguishes genes of some human cancers from their normal counterparts , 1983, Nature.

[15]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[16]  S. Horvath,et al.  Global histone modification patterns predict risk of prostate cancer recurrence , 2005, Nature.

[17]  Rachel Jones,et al.  Behavioural genetics: Worms gang up on bacteria , 2002, Nature Reviews Neuroscience.

[18]  Rachel Jones,et al.  Behavioural genetics: Worms gang up on bacteria , 2002, Nature Reviews Genetics.

[19]  T. Owen-Hughes,et al.  ATP-dependent chromatin remodeling activities , 2001, Cellular and Molecular Life Sciences CMLS.

[20]  D. Picketts,et al.  Cloning and characterization of the murine Imitation Switch (ISWI) genes: differential expression patterns suggest distinct developmental roles for Snf2h and Snf2l , 2001, Journal of neurochemistry.

[21]  J. Workman,et al.  The complexity of chromatin remodeling and its links to cancer. , 2002, Biochimica et biophysica acta.

[22]  B Palcic,et al.  Nuclear texture measurements in image cytometry. , 1995, Pathologica.

[23]  W. Schulz,et al.  DNA methylation in urological malignancies (review). , 1998, International journal of oncology.

[24]  M. Grunstein.  Histone acetylation in chromatin structure and transcription , 1997, Nature.

[25]  Carl Wu,et al.  The ISWI chromatin-remodeling protein is required for gene expression and the maintenance of higher order chromatin structure in vivo. , 2000, Molecular cell.

[26]  P H Bartels,et al.  Chromatin texture in high grade prostatic intraepithelial neoplasia and early invasive carcinoma. , 1999, Analytical and quantitative cytology and histology.

[27]  S. Meng,et al.  p21WAF1 is required for butyrate-mediated growth inhibition of human colon cancer cells , 1998 .

[28]  P H Bartels,et al.  Chromatin texture features in hematoxylin and eosin-stained prostate tissue. , 1993, Analytical and quantitative cytology and histology.

[29]  M Plachot,et al.  Chromosome methylation patterns during mammalian preimplantation development. , 1998, Genes & development.

[30]  R. Poot,et al.  An ACF1–ISWI chromatin-remodeling complex is required for DNA replication through heterochromatin , 2002, Nature Genetics.

[31]  W. Hörz,et al.  ATP-dependent nucleosome remodeling. , 2002, Annual review of biochemistry.

[32]  E. Feinstein,et al.  Expression of prostate specific antigen (PSA) is negatively regulated by p53 , 2002, Oncogene.

[33]  P H Bartels,et al.  Nuclear chromatin texture in prostatic lesions. II. PIN and malignancy associated changes. , 1998, Analytical and quantitative cytology and histology.

[34]  P H Bartels,et al.  Data representation and reduction for chromatin texture in nuclei from premalignant prostatic, esophageal, and colonic lesions. , 2000, Cytometry.

[35]  S. Dhanasekaran,et al.  The polycomb group protein EZH2 is involved in progression of prostate cancer , 2002, Nature.

[36]  A. Blanca,et al.  Histone acetylation and chromatin pattern in cancer: a review. , 2008, Analytical and quantitative cytology and histology.

[37]  J. Jelinek,et al.  Chromatin remodeling gene SMARCA5 is dysregulated in primitive hematopoietic cells of acute leukemia , 2000, Leukemia.

[38]  M. Ehrlich,et al.  DNA methylation in cancer: too much, but also too little , 2002, Oncogene.

[39]  S. Archer,et al.  Histone acetylation and cancer. , 1999, Current opinion in genetics & development.

[40]  R. Poot,et al.  HuCHRAC, a human ISWI chromatin remodelling complex contains hACF1 and two novel histone‐fold proteins , 2000, The EMBO journal.